CPRX vs HZNP
Catalyst Pharmaceuticals Inc (CPRX) versus HZNP (HZNP) — a side-by-side from cached financials, not a winner call.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
HZNP (HZNP) common stock.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
HZNP does not have a complete income-statement cache yet.
CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Not investment advice. Open the CPRX and HZNP stock pages for the full models.
Not investment advice.